Ensysce Biosciences (ENSCW) Free Cash Flow (2020 - 2025)
Historic Free Cash Flow for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to -$1.9 million.
- Ensysce Biosciences' Free Cash Flow fell 8290.21% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.0 million, marking a year-over-year increase of 1751.58%. This contributed to the annual value of -$7.5 million for FY2024, which is 3040.16% up from last year.
- Ensysce Biosciences' Free Cash Flow amounted to -$1.9 million in Q3 2025, which was down 8290.21% from -$2.7 million recorded in Q2 2025.
- In the past 5 years, Ensysce Biosciences' Free Cash Flow registered a high of -$132312.0 during Q2 2021, and its lowest value of -$6.7 million during Q3 2022.
- Its 5-year average for Free Cash Flow is -$2.7 million, with a median of -$2.7 million in 2025.
- In the last 5 years, Ensysce Biosciences' Free Cash Flow tumbled by 325607.81% in 2022 and then skyrocketed by 6630.11% in 2023.
- Ensysce Biosciences' Free Cash Flow (Quarter) stood at -$3.8 million in 2021, then increased by 12.53% to -$3.3 million in 2022, then soared by 45.33% to -$1.8 million in 2023, then skyrocketed by 57.59% to -$764090.0 in 2024, then plummeted by 144.24% to -$1.9 million in 2025.
- Its Free Cash Flow was -$1.9 million in Q3 2025, compared to -$2.7 million in Q2 2025 and -$1.7 million in Q1 2025.